Semustine: Difference between revisions
Content deleted Content added
No edit summary |
m clean up, replaced: it's → its using AWB |
||
| Line 42: | Line 42: | ||
'''Semustine''' is a drug used in [[chemotherapy]].<ref>{{pmid|1548520}}</ref> |
'''Semustine''' is a drug used in [[chemotherapy]].<ref>{{pmid|1548520}}</ref> |
||
It is structurally similar to [[lomustine]], being distinguished from it only by an additional [[methyl]] group. It has been taken off the drug market for investigation of |
It is structurally similar to [[lomustine]], being distinguished from it only by an additional [[methyl]] group. It has been taken off the drug market for investigation of its cancerous effects, rated as [[IARC Group 1 carcinogen]] or a known carcinogen. |
||
==References== |
==References== |
||
{{reflist}} |
{{reflist}} |
||
{{Chemotherapeutic agents}} |
{{Chemotherapeutic agents}} |
||
Revision as of 06:44, 18 May 2012
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.162.271 |
| Chemical and physical data | |
| Formula | C10H18ClN3O2 |
| Molar mass | 247.72 g/mol g·mol−1 |
| (verify) | |
Semustine is a drug used in chemotherapy.[1] It is structurally similar to lomustine, being distinguished from it only by an additional methyl group. It has been taken off the drug market for investigation of its cancerous effects, rated as IARC Group 1 carcinogen or a known carcinogen.
References
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |